Rockefeller Capital Management
ARRY

Rockefeller Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Rockefeller Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,979
Closed -$138K – 2015
2019
Q2 		$138K Buy
2,979
+2,768
+1,312% +$77.7K ﹤0.01% 636
2019
Q1 		$5K Buy
+211
New +$4.39K ﹤0.01% 1653

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Rockefeller Capital Management's ARRY Position: Q3 2019 in Review

Rockefeller Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,979 shares — an estimated $138K sold.

Rockefeller Capital Management first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $138K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Rockefeller Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Rockefeller Capital Management sold 2,979 Array Biopharma Inc shares in Q3 2019, an estimated $138K.
  • Rockefeller Capital Management first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
  • Rockefeller Capital Management's Array Biopharma Inc position peaked at $138K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Rockefeller Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.